Disposal of the Haematology Business

IDS announces the sale of IDS Biocode Hycel’s haematology business to Escalon Medical Corporation (“EMC”), the NASDAQ quoted healthcare company.

Information for Customers:

This change does not have any immediate effect on any of your normal contacts in IDS or Biocode-Hycel. Please continue to contact your local office for all enquiries. More information will be posted on the websites in due course.